-
Je něco špatně v tomto záznamu ?
High Prevalence of Growth Plate Gene Variants in Children With Familial Short Stature Treated With GH
L. Plachy, V. Strakova, L. Elblova, B. Obermannova, S. Kolouskova, M. Snajderova, D. Zemkova, P. Dusatkova, Z. Sumnik, J. Lebl, S. Pruhova,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NV16-31211A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Free Medical Journals
od 1997 do Před 1 rokem
ProQuest Central
od 2017-01-01 do 2020-12-31
Health & Medicine (ProQuest)
od 2017-01-01 do 2020-12-31
PubMed
30753492
DOI
10.1210/jc.2018-02288
Knihovny.cz E-zdroje
- MeSH
- dítě MeSH
- genetická predispozice k nemoci epidemiologie MeSH
- genetická variace * MeSH
- kohortové studie MeSH
- kojenec MeSH
- lidé MeSH
- lidský růstový hormon terapeutické užití MeSH
- metaloendopeptidasy genetika MeSH
- mladiství MeSH
- poruchy růstu farmakoterapie epidemiologie genetika MeSH
- předškolní dítě MeSH
- prognóza MeSH
- prospektivní studie MeSH
- receptor fibroblastových růstových faktorů, typ 3 genetika MeSH
- receptor IGF typ 1 genetika MeSH
- rodokmen MeSH
- růstová ploténka účinky léků MeSH
- sekvenování exomu metody MeSH
- stupeň závažnosti nemoci MeSH
- výsledek terapie MeSH
- Check Tag
- dítě MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
CONTEXT: Familial short stature (FSS) is a term describing a growth disorder that is vertically transmitted. Milder forms may result from the combined effect of multiple genes; more severe short stature is suggestive of a monogenic condition. The etiology of most FSS cases has not been thoroughly elucidated to date. OBJECTIVES: To identify the genetic etiology of severe FSS in children treated with GH because of the diagnosis of small for gestational age or GH deficiency (SGA/GHD). DESIGN, SETTINGS, AND PATIENTS: Of 736 children treated with GH because of GHD/SGA, 33 with severe FSS (life-minimum height -2.5 SD or less in both the patient and shorter parent) were included in the study. The genetic etiology was known in 5 of 33 children prior to the study [ACAN (in 2], NF1, PTPN11, and SOS1). In the remaining 28 of 33, whole-exome sequencing was performed. The results were evaluated using American College of Medical Genetics and Genomics standards and guidelines. RESULTS: In 30 of 33 children (90%), we found at least one variant with potential clinical significance in genes known to affect growth. A genetic cause was elucidated in 17 of 33 (52%). Of these children, variants in growth plate-related genes were found in 9 of 17 [COL2A1, COL11A1, and ACAN (all in 2), FLNB, FGFR3, and IGF1R], and IGF-associated proteins were affected in 2 of 17 (IGFALS and HMGA2). In the remaining 6 of 17, the discovered genetic mechanisms were miscellaneous (TRHR, MBTPS2, GHSR, NF1, PTPN11, and SOS1). CONCLUSIONS: Single-gene variants are frequent among families with severe FSS, with variants affecting the growth plate being the most prevalent.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023635
- 003
- CZ-PrNML
- 005
- 20201214130654.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1210/jc.2018-02288 $2 doi
- 035 __
- $a (PubMed)30753492
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Plachy, Lukas $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
- 245 10
- $a High Prevalence of Growth Plate Gene Variants in Children With Familial Short Stature Treated With GH / $c L. Plachy, V. Strakova, L. Elblova, B. Obermannova, S. Kolouskova, M. Snajderova, D. Zemkova, P. Dusatkova, Z. Sumnik, J. Lebl, S. Pruhova,
- 520 9_
- $a CONTEXT: Familial short stature (FSS) is a term describing a growth disorder that is vertically transmitted. Milder forms may result from the combined effect of multiple genes; more severe short stature is suggestive of a monogenic condition. The etiology of most FSS cases has not been thoroughly elucidated to date. OBJECTIVES: To identify the genetic etiology of severe FSS in children treated with GH because of the diagnosis of small for gestational age or GH deficiency (SGA/GHD). DESIGN, SETTINGS, AND PATIENTS: Of 736 children treated with GH because of GHD/SGA, 33 with severe FSS (life-minimum height -2.5 SD or less in both the patient and shorter parent) were included in the study. The genetic etiology was known in 5 of 33 children prior to the study [ACAN (in 2], NF1, PTPN11, and SOS1). In the remaining 28 of 33, whole-exome sequencing was performed. The results were evaluated using American College of Medical Genetics and Genomics standards and guidelines. RESULTS: In 30 of 33 children (90%), we found at least one variant with potential clinical significance in genes known to affect growth. A genetic cause was elucidated in 17 of 33 (52%). Of these children, variants in growth plate-related genes were found in 9 of 17 [COL2A1, COL11A1, and ACAN (all in 2), FLNB, FGFR3, and IGF1R], and IGF-associated proteins were affected in 2 of 17 (IGFALS and HMGA2). In the remaining 6 of 17, the discovered genetic mechanisms were miscellaneous (TRHR, MBTPS2, GHSR, NF1, PTPN11, and SOS1). CONCLUSIONS: Single-gene variants are frequent among families with severe FSS, with variants affecting the growth plate being the most prevalent.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genetická predispozice k nemoci $x epidemiologie $7 D020022
- 650 12
- $a genetická variace $7 D014644
- 650 _2
- $a poruchy růstu $x farmakoterapie $x epidemiologie $x genetika $7 D006130
- 650 _2
- $a růstová ploténka $x účinky léků $7 D006132
- 650 _2
- $a lidský růstový hormon $x terapeutické užití $7 D019382
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a metaloendopeptidasy $x genetika $7 D008666
- 650 _2
- $a rodokmen $7 D010375
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a receptor fibroblastových růstových faktorů, typ 3 $x genetika $7 D051498
- 650 _2
- $a receptor IGF typ 1 $x genetika $7 D017526
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a sekvenování exomu $x metody $7 D000073359
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Strakova, Veronika $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
- 700 1_
- $a Elblova, Lenka $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
- 700 1_
- $a Obermannova, Barbora $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
- 700 1_
- $a Kolouskova, Stanislava $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
- 700 1_
- $a Snajderova, Marta $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
- 700 1_
- $a Zemkova, Dana $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
- 700 1_
- $a Dusatkova, Petra $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
- 700 1_
- $a Sumnik, Zdenek $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
- 700 1_
- $a Lebl, Jan $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
- 700 1_
- $a Pruhova, Stepanka $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
- 773 0_
- $w MED00002582 $t The Journal of clinical endocrinology and metabolism $x 1945-7197 $g Roč. 104, č. 10 (2019), s. 4273-4281
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30753492 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214130653 $b ABA008
- 999 __
- $a ok $b bmc $g 1595954 $s 1114311
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 104 $c 10 $d 4273-4281 $e 20191001 $i 1945-7197 $m The Journal of clinical endocrinology and metabolism $n J Clin Endocrinol Metab $x MED00002582
- GRA __
- $a NV16-31211A $p MZ0
- LZP __
- $a Pubmed-20201125